Meijssen M A, Tilanus H W, van Blankenstein M, Hop W C, Ong G L
Department of Internal Medicine II, Erasmus University Hospital Dijkzigt, Rotterdam, The Netherlands.
Gut. 1992 Feb;33(2):155-8. doi: 10.1136/gut.33.2.155.
To determine the incidence of oesophageal carcinoma in patients with achalasia and to establish the efficacy of endoscopic surveillance, 195 consecutive patients with achalasia (90 men and 105 women, mean age 52 years), who were treated by pneumatic dilatation in our institution between 1973 and 1988 were prospectively studied. None of the patients had undergone cardiomyotomy. Follow up totalled 874 person years after pneumatic dilatation. In this period three patients developed an oesophageal squamous cell carcinoma. The mean age at diagnosis of the oesophageal carcinoma was 68 years (37, 77, and 89 years). The mean period between the onset of dysphagia and the diagnosis of the tumour was 17 years (19, 28, and 5 years); the mean interval between the diagnosis of achalasia and carcinoma was 5.7 years (5, 8, and 4 years). The incidence of oesophageal squamous cell carcinoma in this series (3.4/1000 patients per year) is significantly higher than the statistically expected incidence (0.104/1000 patients per year) using age and sex specific incidence data from the population of the Netherlands (Poisson statistics: p less than 0.001). The risk of developing oesophageal squamous cell carcinoma in patients with achalasia is therefore increased 33 fold. Periodic endoscopy showed the potential for detecting early stage oesophageal carcinoma in two cases but a larger study with a longer follow up is required to determine the efficacy of endoscopic screening in improving the prognosis for patients with achalasia who develop oesophageal squamous cell carcinoma.
为了确定贲门失弛缓症患者食管癌的发病率,并确定内镜监测的效果,我们对1973年至1988年间在本机构接受气囊扩张治疗的195例连续贲门失弛缓症患者(90例男性和105例女性,平均年龄52岁)进行了前瞻性研究。所有患者均未接受过贲门肌切开术。气囊扩张术后随访总计874人年。在此期间,3例患者发生了食管鳞状细胞癌。食管癌诊断时的平均年龄为68岁(37、77和89岁)。吞咽困难发作至肿瘤诊断的平均时间为17年(19、28和5年);贲门失弛缓症诊断至癌症的平均间隔为5.7年(5、8和4年)。该系列中食管鳞状细胞癌的发病率(每年3.4/1000例患者)显著高于使用荷兰人群年龄和性别特异性发病率数据统计预期的发病率(每年0.104/1000例患者)(泊松统计:p<0.001)。因此,贲门失弛缓症患者发生食管鳞状细胞癌的风险增加了33倍。定期内镜检查显示有两例患者有可能检测到早期食管癌,但需要进行一项随访时间更长的更大规模研究,以确定内镜筛查对改善发生食管鳞状细胞癌的贲门失弛缓症患者预后的效果。